CONDENSED CONSOLIDATED STATEMENTS OF LOSS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
Mar. 31, 2025	Mar. 31, 2024
Income Statement [Abstract]
Net product revenue	$ 52,511	$ 27,178
Cost of products sold	5,577	1,522
Gross profit	46,934	25,656
Operating expenses:
Research and development expenses	4,354	3,068
Selling, general and administrative expenses	45,581	48,623
Total operating expense	49,935	51,691
Operating loss	(3,001)	(26,035)
Investment and other income, net	397	1,378
Interest expense	(2,238)	(2,592)
Loss before income taxes	(4,842)	(27,249)
Income tax provision	78	93
Net loss	$ (4,920)	$ (27,342)
Net loss per share - basic (in dollars per share)	$ (0.05)	$ (0.30)
Net loss per share - diluted (in dollars per share)	$ (0.05)	$ (0.30)
Weighted average number of shares outstanding - basic (in shares)	96,601	91,693
Weighted average number of shares outstanding - diluted (in shares)	96,601	91,693

The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.

Name:	us-gaap_CostOfGoodsAndServicesSold
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.